Persephone Biosciences
We are using the gut microbiome to end cancer.
Y CombinatorWinter 2018ActiveHealthcareTherapeuticsAI-powered Drug DiscoveryCOVID-19
What they do
Problem
Cancer patients and clinicians lack effective therapies that leverage the gut microbiome to improve prevention and treatment outcomes.
Solution
The company develops engineered live biotherapeutic products that modulate gut microbiome metabolism using systems and synthetic biology.
Who it's for
Oncologists and enterprise healthcare providers treating cancer patients.
Founders
Stephanie Culler
Founder/CEO
Stephen Van Dien
Founder/CTO
Company timeline
- Founded2017
- YC batchWinter 2018
- StatusActive
- Team size6 people
- LocationSan Diego, CA, USA
Similar startups
CB Therapeutics
Fermentation-derived natural products to solve health problems
Humane Genomics
A platform to make artificial viruses as cancer therapeutics.
Equator Therapeutics
We are developing a drug to burn calories and increase metabolism…
Rejuvenation Technologies Inc.
mRNA therapeutics to extend healthspan entering clinical trials
Promakhos Therapeutics
A therapeutics platform for curing inflammatory disorders
SynsoryBio
"If-then" conditional logic for protein drugs